Cargando…

Papillary Thyroid Cancer With Pituitary Gland Metastasis: A Unique Encounter

The pituitary gland is a rare metastatic site, and thyroid cancer (TC) metastasis to the pituitary gland is immensely uncommon. We report the case of a 45-year-old male in whom pituitary metastasis (PM) discovery during the immediate postoperative period complicated the management of papillary thyro...

Descripción completa

Detalles Bibliográficos
Autores principales: Butt, Muhammad I, Siddiqi, Ahmad M, Joueidi, Faisal M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224753/
https://www.ncbi.nlm.nih.gov/pubmed/37252592
http://dx.doi.org/10.7759/cureus.38210
_version_ 1785050265205866496
author Butt, Muhammad I
Siddiqi, Ahmad M
Joueidi, Faisal M
author_facet Butt, Muhammad I
Siddiqi, Ahmad M
Joueidi, Faisal M
author_sort Butt, Muhammad I
collection PubMed
description The pituitary gland is a rare metastatic site, and thyroid cancer (TC) metastasis to the pituitary gland is immensely uncommon. We report the case of a 45-year-old male in whom pituitary metastasis (PM) discovery during the immediate postoperative period complicated the management of papillary thyroid cancer (PTC). His postoperative magnetic resonance imaging (MRI) of the pituitary lesion showed a progression in size with persistent optic nerve compression. The critical location of the pituitary lesion and the rapid progression dictated the treatment course. The pituitary lesion was non-iodine avid, and thus we opted for external beam radiation therapy (EBRT). He received 1,200 centigray (cGy) with Gamma knife radiosurgery with steroid cover. In our case, the aggressive histological and clinical variant of PTC consisted of multiple metastatic sites involving large volume pulmonary, skeletal, and chest wall lesions coupled with crucial macro metastatic pituitary mass. The patient was offered radioactive iodine to treat other iodine avid metastases in the lungs and bones and was also offered EBRT to target skeletal lesions. Systemic treatment with tyrosine kinase inhibitor was also discussed with the patient. Our case encourages clinicians to exercise vigilance and a high index of suspicion for PM when a patient with any pre-existing cancer presents with visual disturbance, cranial nerve deficit, or symptoms suggestive of hormonal deficiency. It also highlights the importance of involving endocrinologists before performing any surgery on the endocrine organs to ascertain the integrity of the endocrine function of the glands.
format Online
Article
Text
id pubmed-10224753
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-102247532023-05-28 Papillary Thyroid Cancer With Pituitary Gland Metastasis: A Unique Encounter Butt, Muhammad I Siddiqi, Ahmad M Joueidi, Faisal M Cureus Endocrinology/Diabetes/Metabolism The pituitary gland is a rare metastatic site, and thyroid cancer (TC) metastasis to the pituitary gland is immensely uncommon. We report the case of a 45-year-old male in whom pituitary metastasis (PM) discovery during the immediate postoperative period complicated the management of papillary thyroid cancer (PTC). His postoperative magnetic resonance imaging (MRI) of the pituitary lesion showed a progression in size with persistent optic nerve compression. The critical location of the pituitary lesion and the rapid progression dictated the treatment course. The pituitary lesion was non-iodine avid, and thus we opted for external beam radiation therapy (EBRT). He received 1,200 centigray (cGy) with Gamma knife radiosurgery with steroid cover. In our case, the aggressive histological and clinical variant of PTC consisted of multiple metastatic sites involving large volume pulmonary, skeletal, and chest wall lesions coupled with crucial macro metastatic pituitary mass. The patient was offered radioactive iodine to treat other iodine avid metastases in the lungs and bones and was also offered EBRT to target skeletal lesions. Systemic treatment with tyrosine kinase inhibitor was also discussed with the patient. Our case encourages clinicians to exercise vigilance and a high index of suspicion for PM when a patient with any pre-existing cancer presents with visual disturbance, cranial nerve deficit, or symptoms suggestive of hormonal deficiency. It also highlights the importance of involving endocrinologists before performing any surgery on the endocrine organs to ascertain the integrity of the endocrine function of the glands. Cureus 2023-04-27 /pmc/articles/PMC10224753/ /pubmed/37252592 http://dx.doi.org/10.7759/cureus.38210 Text en Copyright © 2023, Butt et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Butt, Muhammad I
Siddiqi, Ahmad M
Joueidi, Faisal M
Papillary Thyroid Cancer With Pituitary Gland Metastasis: A Unique Encounter
title Papillary Thyroid Cancer With Pituitary Gland Metastasis: A Unique Encounter
title_full Papillary Thyroid Cancer With Pituitary Gland Metastasis: A Unique Encounter
title_fullStr Papillary Thyroid Cancer With Pituitary Gland Metastasis: A Unique Encounter
title_full_unstemmed Papillary Thyroid Cancer With Pituitary Gland Metastasis: A Unique Encounter
title_short Papillary Thyroid Cancer With Pituitary Gland Metastasis: A Unique Encounter
title_sort papillary thyroid cancer with pituitary gland metastasis: a unique encounter
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224753/
https://www.ncbi.nlm.nih.gov/pubmed/37252592
http://dx.doi.org/10.7759/cureus.38210
work_keys_str_mv AT buttmuhammadi papillarythyroidcancerwithpituitaryglandmetastasisauniqueencounter
AT siddiqiahmadm papillarythyroidcancerwithpituitaryglandmetastasisauniqueencounter
AT joueidifaisalm papillarythyroidcancerwithpituitaryglandmetastasisauniqueencounter